Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 7, 2011 - Issue
Submit an article Journal homepage
106
Views
13
CrossRef citations to date
0
Altmetric
Expert Opinion

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

Roger S McIntyre1 Department of Psychiatry, University of Toronto, Toronto, ON, Canada;2 Department of Pharmacology, University of Toronto, Toronto, ON, Canada;3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;4 Institute of Medical Science, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]
,
Jinju Yoon3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada
,
Jeanette M Jerrell5 Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC, USA
&
Samantha S Liauw3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada
Pages 319-323 | Published online: 25 May 2011

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Alessandro Cuomo, Bruno Beccarini Crescenzi, Arianna Goracci, Simone Bolognesi, Nicola Giordano, Rodolfo Rossi, Edvige Facchi, Stephen M Neal & Andrea Fagiolini. (2019) Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 18:6, pages 455-463.
Read now
Gul Eryilmaz, Gökben Hizli Sayar, Eylem Özten, Işil Göğcegöz Gül, Oğuz Karamustafalioğlu & Özgür Yorbik. (2014) Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients. International Journal of Psychiatry in Clinical Practice 18:4, pages 288-292.
Read now
Peter Paul De Deyn, Annemieke FJ Drenth, Berry P Kremer, Richard C Oude Voshaar & Debby Van Dam. (2013) Aripiprazole in the treatment of Alzheimer's disease. Expert Opinion on Pharmacotherapy 14:4, pages 459-474.
Read now
Melanie Zupancic & Misty L Gonzalez. (2012) Aripiprazole in the acute and maintenance phase of bipolar I disorder. Therapeutics and Clinical Risk Management 8, pages 1-6.
Read now

Articles from other publishers (9)

Pawan Devangan, Aakash Saini, Digeshwari Patel & Ujwal Kolhe. (2023) Solubility Enhancement of Aripiprazole via Mesoporous Silica: Preparation, Characterization, In vitro Drug Release, and Solubility Determination. Journal of Pharmaceutical Innovation.
Crossref
Jung Goo Lee, Won-Myong Bahk, Young Sup Woo, Jong-Hyun Jeong, Jeong Seok Seo, IL Han Choo, Chan-Mo Yang, Won Kim, Se-Hoon Shim, Myung Hun Jung, Duk-In Jon, Sung-Yong Park, InKi Sohn, Moon-Doo Kim & Bo-Hyun Yoon. (2022) Korean Medication Algorithm Project for Bipolar Disorder 2022: Maintenance Therapy. Journal of Korean Neuropsychiatric Association 61:3, pages 214.
Crossref
Assel Sarsenbayeva, Cátia M. Marques-Santos, Ketan Thombare, Giada Di Nunzio, Kristina E. Almby, Martin Lundqvist, Jan W. Eriksson & Maria J. Pereira. (2019) Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism. Psychoneuroendocrinology 110, pages 104445.
Crossref
Joseph R. Calabrese, Na Jin, Brian Johnson, Pedro Such, Ross A. Baker, Jessica Madera, Peter Hertel, Jocelyn Ottinger, Joan Amatniek & Hiroaki Kawasaki. (2018) Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study. International Journal of Bipolar Disorders 6:1.
Crossref
Young Sup Woo, Won-Myong Bahk, Young-Min Park, Sangkeun Chung, Bo-Hyun Yoon, Seunghee Won, Jeong Goo Lee, Hwang-Bin Lee, Won Kim, Jong-Hyun Jeong, Kwanghun Lee & Moon-Doo Kim. (2016) Effects of switching to aripiprazole from current atypical antipsychotics on subsyndromal symptoms and tolerability in patients with bipolar disorder. International Clinical Psychopharmacology 31:5, pages 275-286.
Crossref
Rao N. Malempati. (2015) Aripiprazole Adjunct Treatment in Bipolar I or II Disorder, Depressed State. Journal of Nervous & Mental Disease 203:1, pages 58-64.
Crossref
J. Peuskens, L. Pani, J. Detraux & M. De Hert. (2014) The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs.
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry 89 154 .
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry 31 88 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.